Assessing Haleon plc's Dividend Prospects Amid Flat Earnings

Haleon plc, a notable player in the,healthcare sector,, is approaching its ex-dividend date in just three days, which may be of interest to shareholde...

Oncimmune Holdings PLC Secures $1.5 Million Contract

Oncimmune Holdings PLC (LSE: ONC), a company specializing in autoantibody profiling, has secured a new contract with a leading global pharmaceutical f...

How Did MaxCyte Perform in Its Second-Quarter Results?

MaxCyte, Inc. an,Healthcare sector,firm has released its second-quarter results, showcasing stronger-than-expected performance. The company's revenue...

Hikma Pharmaceuticals Reports Increased Profit and Dividend Amid Str...

Hikma Pharmaceuticals PLC (LSE: HIK) has reported financial results for the first half of 2024. The company’s pretax profit increased by 43%, reaching...

Assura plc Expands into Private Healthcare with £500 Million Acquisi...

Assura plc (LSE:AGR), a leading UK healthcare property investor and developer, has announced a major expansion into the private healthcare sector with...

Faron Pharma Shares Rise After New CMO Appointment

Faron Pharmaceuticals Limited, operating in the,healthcare sector,, announced the appointment of Dr. Petri Bono as its new Chief Medical Officer (CMO)...

Genedrive Shares Drop 10% Following CEO Departure

Genedrive PLC, operating in the,Healthcare sector,, saw its shares decline by 10% following the announcement that CEO James Cheek has left the company...

Glencore's EBITDA Falls in H1 2024 Results, Driven by Normalized Ene...

Glencore PLC (LSE:GLEN) reported a mixed set of results for the first half of 2024, reflecting significant shifts in the energy markets. The company's...

Haleon PLC Appoints New Non-Executive Directors

Haleon PLC (LSE: HLN), the consumer healthcare company headquartered in Weybridge, Surrey, has announced the appointment of Alan Stewart and Nancy Avi...

GSK Declares £0.15 Dividend, Increasing Returns for Stakeholders

A significant player of,Healthcare Sector,GlaxoSmithKline PLC,has declared a dividend payment of £0.15 per share, scheduled for October 10th. This div...

Faron Pharmaceuticals Appoints Dr. Petri Bono as New Chief Medical O...

Faron Pharmaceuticals Ltd. (AIM:FARN), a clinical-stage biopharmaceutical company focused on pioneering CLEVER-1 receptor-targeting approaches to enha...

GSK Triumphs in Illinois Court, Jury Finds No Cancer Link to Ranitid...

GSK plc (LSE/NYSE:GSK) announced today that a jury in Illinois state court has ruled in its favor in the Joiner case. This decision is a significant v...

Why Johnson Matthey’s High P/E Ratio Deserves Closer Watch?

Johnson Matthey PLC’s (LSE: JMAT) P/E ratio of 26.6x is notably higher than the UK market average of around 16x. This ratio indicates that investors h...

IXICO Appoints New CEO, Bram Goorden

IXICO plc (AIM:IXI), a leading precision analytics company specializing in neuroscience, is pleased to announce the appointment of Bram Goorden as Chi...

hVIVO to Cancel Euronext Growth Listing to Focus on AIM Market

hVIVO plc (AIM:HVO), a leading specialist contract research organization (CRO) renowned for its expertise in human challenge clinical trials for infec...

Haleon Announces Increase in 1H 2024 Interim Dividend

Haleon plc (LSE/NYSE:,HLN,) has announced its half-year results for the period ending 31 December 2024, along with a significant increase in its inter...

Smith+Nephew Reports 1H and 2Q Results, Maintains 2024 Guidance

Smith+Nephew (LSE: SN, NYSE:,SNN,), a global medical technology company, reported its financial results for the second quarter and the first half ende...

Croda International Share Price Falls 62% Today. Here’s Why.

Croda International (,LSE:CRDA,), a chemicals company renowned for its high-quality products used in various industries, has seen its share price decl...

GSK Gains Limelight With Upgraded 2024 Guidance

GSK (,LSE:GSK,) has delivered a strong financial performance for the second quarter of 2024, demonstrating substantial growth across its portfolio. Th...

Genedrive (AIM: GDR) Receives FDA Breakthrough Device Designation fo...

Genedrive plc (,AIM: GDR,), a leader in point-of-care pharmacogenetic testing, has announced the receipt of Breakthrough Device Designation from the U...